Neuranix S.r.l. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2017

Location

Napoli Italy

Primary Industry

Healthcare

About

Based in Napoli, Italy, and founded in 2017 by Filip Moens (CEO), Biosline Holding, and Lorenzo Caporaletti, Neuranix S.r.l. operates as a healthcare company that develops and manufactures medical devices for people and pets with ear disorders. In July 2022, Neuranix S.r.l. raised EUR 2.1 million in seed funding from Bios Line Holding, with participation from CDP Venture Capital and individual investors also participating in the round. Neuranix S.r.l. provides a medical device for two product families and pets to get hearing function measured in the outer ear and middle ear. The firm developed two devices namely vet-wave and med-wave. Vet-wave is developed for the veterinary field and is already in the international marketing phase. Med-wave is for ENT-related disorders. The company plans to use the July 2022 funding to strengthen its organization, finance the process of go-to-market and prepare the launch of new PLAI technology-based products.

Current Investors

CDP Venture Capital, Bios Line Holding

Request a demo to show more

Primary Industry

Healthcare

Sub Industries

Diagnostic Equipment, Medical Equipment Distributors, Therapeutic Devices

Website

www.neuranix.com

Verticals

HealthTech, Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.